13D/13G Filings - Mitchell P. Kopin

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...3, 4, 5, 6, 7, ...13, 14, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-06
10:29 am
Purchase
2023-12-3113GPalisade Bio, Inc.
PALI
Mitchell P. Kopin12,035
1.900%
3,296increase
(+37.72%)
Filing
History
2024-02-06
10:27 am
Sale
2023-12-3113GKiora Pharmaceuticals, Inc.
KPRX
Mitchell P. Kopin13,012
1.500%
-6,185decrease
(-32.22%)
Filing
History
2024-02-06
10:24 am
Unchanged
2023-12-3113GNAYA Biosciences, Inc.
NAYA
Mitchell P. Kopin15,333
6.900%
0
(Unchanged)
Filing
History
2024-02-06
10:24 am
Purchase
2023-12-3113GPerformance Shipping Inc.
PSHG
Mitchell P. Kopin472,800
3.900%
206,134increase
(+77.30%)
Filing
History
2024-02-06
10:23 am
Sale
2023-12-3113GPetros Pharmaceuticals, Inc.
PTPI
Mitchell P. Kopin6,191
6.600%
-495decrease
(-7.40%)
Filing
History
2024-02-06
10:22 am
Purchase
2023-12-3113GHelius Medical Technologies, Inc.
HSDT
Mitchell P. Kopin1
0.100%
1increase
(New Position)
Filing
History
2024-02-06
10:19 am
Purchase
2023-12-3113GGuardion Health Sciences, Inc.
GHSI
Mitchell P. Kopin50,000
3.800%
50,000increase
(New Position)
Filing
History
2024-02-06
10:17 am
Sale
2023-12-3113GEnveric Biosciences, Inc.
ENVB
Mitchell P. Kopin644
6.200%
-272decrease
(-29.66%)
Filing
History
2024-02-06
10:16 am
Purchase
2023-12-3113GSynaptogenix, Inc.
SNPX
Mitchell P. Kopin41,929
4.990%
10,460increase
(+33.24%)
Filing
History
2024-02-06
10:14 am
Purchase
2023-12-3113GAgile Therapeutics, Inc.
AGRX
Mitchell P. Kopin23,961
0.900%
23,961increase
(New Position)
Filing
History
2024-02-06
10:12 am
Unchanged
2023-12-3113GTian Ruixiang Holdings Ltd
TIRX
Mitchell P. Kopin53,667
8.100%
0
(Unchanged)
Filing
History
2024-02-06
10:11 am
Purchase
2023-12-3113GAntelope Enterprise Holdings Limited
AEHL
Mitchell P. Kopin2,751
4.990%
2,751increase
(New Position)
Filing
History
2024-02-06
10:06 am
Purchase
2023-12-3113GAditxt, Inc.
ADTX
Mitchell P. Kopin1
1.500%
1increase
(New Position)
Filing
History
2024-02-06
10:04 am
Unchanged
2023-12-3113GDMK Pharmaceuticals Corporation
DMKPQ
Mitchell P. Kopin650,000
6.000%
0
(Unchanged)
Filing
History
2024-02-06
09:56 am
Sale
2023-12-3113GPharmaCyte Biotech, Inc.
PMCB
Mitchell P. Kopin903,412
9.990%
-1,015,547decrease
(-52.92%)
Filing
History
2024-02-06
09:52 am
Purchase
2023-12-3113GClearmind Medicine Inc.
CMND
Mitchell P. Kopin88,925
4.990%
88,925increase
(New Position)
Filing
History
2024-02-02
4:10 pm
Purchase
2024-01-2513GRedHill Biopharma Ltd.
RDHL
Mitchell P. Kopin2,000
4.000%
2,000increase
(New Position)
Filing
History
2023-11-27
06:10 am
Purchase
2023-11-1613GBone Biologics Corporation
BBLG
Mitchell P. Kopin4,676
4.990%
4,676increase
(New Position)
Filing
History
2023-08-11
4:18 pm
Purchase
2023-08-0413GNAYA Biosciences, Inc.
NAYA
Mitchell P. Kopin15,333
7.100%
15,333increase
(New Position)
Filing
History
2023-08-10
4:03 pm
Purchase
2023-08-0113GDMK Pharmaceuticals Corporation
DMKPQ
Mitchell P. Kopin650,000
7.600%
650,000increase
(New Position)
Filing
History
Goto Prev, 0, 1, ...3, 4, 5, 6, 7, ...13, 14, Next